Ключевые слова:
gastric cancer, personalized therapy, morphology, immunohistochemistry, advanced cancer.Библиографические ссылки
Blinov N.N., Kozlov N.A., Fedorenko A.A. Immunohistochemical markers in the diagnosis and prognosis of gastric cancer. Archive of Pathology, 2018; 80(6): 38–45.
Davydov M.I., Stilidi I.S. Gastric Cancer: Modern Approaches to Diagnosis and Treatment. Moscow: MIA, 2018. 352 p.
Gantsev Sh.Kh., Gallyamov A.R. Modern principles of systemic therapy for gastric cancer. Practical Oncology, 2020; 21(3): 215–224Kaprin A.D., Starinsky V.V., Petrova G.V. Malignant Neoplasms in Russia in 2020: Incidence and Mortality. Moscow: P.A. Herzen Moscow Oncology Research Institute, 2021. 252 p.
Kuznetsov M.A., Subbotin V.M. Morphological heterogeneity of gastric cancer and its clinical significance. Problems in Oncology, 2017; 63(5): 702–708.
Lavrova E.A., Zlokazov A.S., Morozov S.V. HER2 and Ki-67 expression in gastric cancer and their prognostic significance. Clinical and Experimental Morphology, 2019; (4): 28–34.
Pisarev V.M., Kudryavtsev A.Yu., Zhukova L.G. Peritoneal carcinomatosis in gastric cancer: clinical and morphological aspects. Oncology. P.A. Herzen Journal, 2020; 9(4): 45–52.
Stilidi I.S., Davydov M.I., Nikulin M.P. Combined treatment of locally advanced gastric cancer. Bulletin of the N.N. Blokhin National Medical Research Center of Oncology, 2019; 30(2): 5–14.